Aspen Aerogels, Inc. (NYSE:ASPN) Receives $19.00 Consensus Target Price from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has earned an average rating of “Buy” from the five analysts that are covering the company, MarketBeat reports. Five analysts have rated the stock with a buy recommendation. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $19.00.

Several research analysts have recently issued reports on the company. TheStreet upgraded Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Roth Mkm began coverage on Aspen Aerogels in a report on Wednesday, March 6th. They issued a “buy” rating and a $22.00 price objective on the stock. Finally, HC Wainwright reissued a “buy” rating and set a $20.00 target price on shares of Aspen Aerogels in a report on Wednesday, February 14th.

Aspen Aerogels Price Performance

Shares of Aspen Aerogels stock opened at $16.10 on Friday. The firm has a market cap of $1.24 billion, a PE ratio of -24.39 and a beta of 2.04. The stock has a 50 day moving average of $16.49 and a 200 day moving average of $13.31. The company has a current ratio of 3.41, a quick ratio of 2.91 and a debt-to-equity ratio of 0.24. Aspen Aerogels has a 12 month low of $5.32 and a 12 month high of $19.10.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings data on Tuesday, February 13th. The construction company reported ($0.01) EPS for the quarter, beating the consensus estimate of ($0.12) by $0.11. The company had revenue of $84.22 million for the quarter, compared to the consensus estimate of $83.82 million. Aspen Aerogels had a negative return on equity of 10.47% and a negative net margin of 19.19%. During the same quarter in the prior year, the company posted ($0.20) EPS. On average, research analysts expect that Aspen Aerogels will post -0.24 EPS for the current fiscal year.

Institutional Trading of Aspen Aerogels

Hedge funds have recently bought and sold shares of the company. Portside Wealth Group LLC acquired a new stake in Aspen Aerogels during the 2nd quarter worth approximately $80,000. Banque Cantonale Vaudoise lifted its position in shares of Aspen Aerogels by 37.5% during the 1st quarter. Banque Cantonale Vaudoise now owns 4,593 shares of the construction company’s stock valued at $81,000 after acquiring an additional 1,252 shares during the period. McAdam LLC bought a new position in shares of Aspen Aerogels during the 4th quarter worth about $191,000. Mirae Asset Global Investments Co. Ltd. increased its position in Aspen Aerogels by 71.4% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 23,052 shares of the construction company’s stock valued at $198,000 after buying an additional 9,601 shares in the last quarter. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its stake in Aspen Aerogels by 38.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 12,971 shares of the construction company’s stock worth $205,000 after buying an additional 3,607 shares during the period. Institutional investors and hedge funds own 97.64% of the company’s stock.

About Aspen Aerogels

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.